Bill Sutherland: Back to healthcare just for a second. I was thinking about the comments Brad you made about behavioral health, really taking off is it – I mean, where are you in terms of its importance to you? In other words, is it becoming a meaningful percentage of revenue yet or you are still just starting that process?
Kevin Miller: I think, it is the majority of the business at this point. And frankly, we anticipate seeing it accelerate. As we have been pretty excited about the story and positioned ourselves for it accordingly. The last couple of years. I wouldn’t call it on the come, there is certainly a bit of an increasing drum beat. But I think, you call it nine, 12-months, I think you are seeing a meaningful increase, and we anticipate that that activity continuing to go in the right direction. I think naturally you think about some of the drivers of this from a macro perspective oftentimes investment behind these type of social infrastructure initiatives are going to come on a lag. And we think that is exactly what we are seeing. So, very exciting part of the portfolio, no question about it. We think that there is plenty of upside there. And we are certainly willing to keep everybody posted as that continues to crystallize.
Brad Vizi: And I would add to that Bill that, three years ago our behavioral health revenue three, four years ago was primarily coming from two clients. So today, we have well over 30 that we are providing behavioral health services to. And as when I look at this behavioral health market for RCM, we are still in the first inning second at best, right. So, we just think there is amazing potential there. We just think there is so much growth out there. Now, obviously, there is a lot of competition, there is a lot of other companies that are going after this business, but there is just, there is a lot of business out there for us to grab and we think our team is stellar. And we are really excited to grab it. There is only so much you can grab in one school year, because once the contracts are set for that school year that you are not going to typically add like a $5 million client in the middle of school year.
But we have a lot of potential to build with the 30 schools that approximately 30 schools that we are providing behavioral health. And then hopefully when we get the next school year, we will add another 20, another 30. We will see – it is a really exciting business to be in and we will bump about it.
Bill Sutherland: Roughly how many schools are you in now total year?
Brad Vizi: Probably about 70. Where we are active, roughly.
Operator: [Operator Instructions] It looks like we have a question from [Frank Kelly] (Ph). Your line is open.
Unidentified Analyst: In particular, life science is heading to 40% phenomenal, absolutely outstanding. And love to see top line growth there and that unit take over. Switching over to the balance sheet on actual trade accounts receivable, what can you shed some light on there? It just seems to see that we are losing significant traction since our last call and since year end 12/31/22.
Kevin Miller: Sure. I can speak about that, Frank. We talked a little bit on the last call. So the receivables relative to where the revenue right now are just too high, the treasury receivables period. And we are doing a lot of different things to get them down and get our DSOs to a better level. But as I think you – because you have fought these battles before in your career, that when you get into Q3, because our revenue is somewhat back loaded into September, because of the schools being closed in June July, we are always going to have sort of a wacky-looking receivable/DSO in Q3 because of the cadence of how the revenue hits the income statement. Obviously, you are not going to have any receivables to collect in October relative to September, or at least very little.
